Cytogenix (fka CYGX)

[gutaquest]

arnold, You are correct, CYGX has never had a product to build a business plan around.

The invention of synDNA and the synDNA validation process CYGX has gone through sets the stage for presenting a business plan to raise the necessary financing.

With the amount of venture capital that is available, CYGX should be able to raise the necessary capital with a minimum of dilution to the present stockholders.

Gutaquest